|
Molecular Insight currently has two clinical trials underway for Azedra:
Phase I/II Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
Phase 2a Study of Ultratrace™ Iobenguane I 131 in Patients With Relapsed or Refractory High-Risk Neuroblastoma
|